NanoBone®
-
Biologics
Biocomposites adds proprietary NanoBone® technology to its portfolio through the acquisition of Artoss GmbH
NanoBone® technology complements Biocomposites’ absorbable bone regeneration products Artoss to benefit from Biocomposites established, global distribution network KEELE, England, June 6, 2023 /PRNewswire/…
Read More » -
Financial
Artoss, Inc. Announces Record Sales of NanoBone® Bone Graft
Press Release October 5, 2020 Artoss, Inc. is pleased to announce that it achieved record sales of NanoBone Bone Graft…
Read More » -
Regulatory
Artoss, Inc. Announces FDA Clearance of NanoBone® SBX Putty for Standalone Use in Posterolateral Spinal Fusion
April 24, 2019 Artoss, Inc. is pleased to announce that the US Food & Drug Administration has cleared NanoBone SBX…
Read More » -
Biologics
Artoss Announces NanoBone® QD Bone Graft
Press Release/October 23, 2017 Artoss, Inc. is pleased to announce NanoBone QD Bone Graft. Paul Byerley, Managing Director of Artoss,…
Read More » -
Biologics
Artoss Announces FDA Clearance to Market of NanoBone® SBX Putty
November 8, 2016 Artoss, Inc. is pleased to announce that, on October 26, 2016, Artoss GmbH received notice from the…
Read More »